Yunfei Lu
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
-
- Ubiquitin and proteasome pathways 2
- Co-authors
- Xiaorong Chen (7 shared papers)Zongguo Yang (20 shared papers)Wei Zhang (2 shared papers)Zhenwei Wang (1 shared paper)Feifei Chen (1 shared paper)Qingnian Xu (16 shared papers)Xiaorong Chen (16 shared papers)Bozong Tang (11 shared papers)
- Journals
- Medicine (2 papers)Oncotarget (2 papers)BioMed Research International (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)American Journal of Respiratory and Critical Care Medicine (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yunfei Lu
44 papers receiving 2.1k citations
Yunfei Lu's Hit Papers
Peers
Comparison fields: 5 of 126
- Infectious Diseases 844
- Neurology 332
- Applied Microbiology and Biotechnology 31
- Hepatology 111
- Complementary and alternative medicine 98
Countries citing papers authored by Yunfei Lu
This map shows the geographic impact of Yunfei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunfei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunfei Lu more than expected).
Fields of papers citing papers by Yunfei Lu
This network shows the impact of papers produced by Yunfei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunfei Lu. The network helps show where Yunfei Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yunfei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 with Different Severities: A Multicenter Study of Clinical Features Hit paper breakdown → | 2020 | 602 |
| 2 | 2020 | 420 | |
| 3 | 2015 | 146 | |
| 4 | 2020 | 117 | |
| 5 | 2020 | 84 | |
| 6 | 2020 | 71 | |
| 7 | 2015 | 66 | |
| 8 | 2015 | 64 | |
| 9 | 2021 | 41 | |
| 10 | 2016 | 37 | |
| 11 | 2020 | 36 | |
| 12 | 2014 | 34 | |
| 13 | 2017 | 33 | |
| 14 | 2012 | 32 | |
| 15 | 2020 | 31 | |
| 16 | 2016 | 29 | |
| 17 | 2020 | 28 | |
| 18 | 2019 | 22 | |
| 19 | Elevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: a retrospective analysis. | 2015 | 21 |
| 20 | 2020 | 20 |
About Yunfei Lu
Yunfei Lu is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Hepatology and Cancer Research, having authored 46 papers that have together received 2.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), COVID-19 Clinical Research Studies (4 papers), Hepatitis B Virus Studies (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Ubiquitin and proteasome pathways (2 papers), Ferroptosis and cancer prognosis (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Infectious Diseases (844 citations), Neurology (332 citations), Applied Microbiology and Biotechnology (31 citations), Hepatology (111 citations) and Complementary and alternative medicine (98 citations). Yunfei Lu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiaorong Chen, Zongguo Yang, Wei Zhang, Zhenwei Wang, Feifei Chen, Qingnian Xu, Xiaorong Chen, Bozong Tang, Liping Zhuang and Yun Ling. Their work appears in journals such as Medicine, Oncotarget, BioMed Research International, Evidence-based Complementary and Alternative Medicine and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.